nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—HTR1D—migraine	0.282	0.628	CbGaD
Almotriptan—HTR1B—migraine	0.167	0.372	CbGaD
Almotriptan—HTR1B—Propranolol—migraine	0.0482	0.138	CbGbCtD
Almotriptan—HTR1D—Amitriptyline—migraine	0.0435	0.124	CbGbCtD
Almotriptan—HTR1B—Amitriptyline—migraine	0.0417	0.119	CbGbCtD
Almotriptan—CYP2E1—Amitriptyline—migraine	0.0174	0.0498	CbGbCtD
Almotriptan—CYP2C19—Timolol—migraine	0.0142	0.0405	CbGbCtD
Almotriptan—CYP2C8—Amitriptyline—migraine	0.013	0.0372	CbGbCtD
Almotriptan—CYP2C19—Propranolol—migraine	0.0126	0.0361	CbGbCtD
Almotriptan—CYP2C8—Valproic Acid—migraine	0.0119	0.0339	CbGbCtD
Almotriptan—CYP1A2—Propranolol—migraine	0.0116	0.0333	CbGbCtD
Almotriptan—CYP2C19—Amitriptyline—migraine	0.0109	0.0312	CbGbCtD
Almotriptan—CYP2D6—Timolol—migraine	0.0108	0.0308	CbGbCtD
Almotriptan—CYP2C8—Verapamil—migraine	0.0103	0.0295	CbGbCtD
Almotriptan—CYP1A2—Amitriptyline—migraine	0.0101	0.0288	CbGbCtD
Almotriptan—CYP2C19—Valproic Acid—migraine	0.00995	0.0284	CbGbCtD
Almotriptan—CYP2D6—Propranolol—migraine	0.0096	0.0274	CbGbCtD
Almotriptan—HTR1B—trigeminal nucleus—migraine	0.00928	0.165	CbGeAlD
Almotriptan—CYP1A2—Valproic Acid—migraine	0.00918	0.0262	CbGbCtD
Almotriptan—HTR1D—trigeminal nucleus—migraine	0.00898	0.16	CbGeAlD
Almotriptan—CYP2C19—Topiramate—migraine	0.00898	0.0256	CbGbCtD
Almotriptan—CYP2C19—Verapamil—migraine	0.00866	0.0247	CbGbCtD
Almotriptan—CYP2D6—Amitriptyline—migraine	0.0083	0.0237	CbGbCtD
Almotriptan—CYP1A2—Verapamil—migraine	0.00799	0.0228	CbGbCtD
Almotriptan—CYP2D6—Verapamil—migraine	0.00659	0.0188	CbGbCtD
Almotriptan—CYP3A4—Propranolol—migraine	0.0061	0.0174	CbGbCtD
Almotriptan—HTR1D—meninx—migraine	0.00596	0.106	CbGeAlD
Almotriptan—HTR1B—dura mater—migraine	0.00567	0.101	CbGeAlD
Almotriptan—HTR1D—dura mater—migraine	0.00549	0.0975	CbGeAlD
Almotriptan—CYP3A4—Amitriptyline—migraine	0.00528	0.0151	CbGbCtD
Almotriptan—CYP3A4—Valproic Acid—migraine	0.00481	0.0137	CbGbCtD
Almotriptan—CYP3A4—Topiramate—migraine	0.00434	0.0124	CbGbCtD
Almotriptan—CYP3A4—Verapamil—migraine	0.00419	0.012	CbGbCtD
Almotriptan—HTR1B—trigeminal nerve—migraine	0.00244	0.0433	CbGeAlD
Almotriptan—HTR1D—trigeminal nerve—migraine	0.00236	0.0419	CbGeAlD
Almotriptan—MAOA—locus ceruleus—migraine	0.00219	0.039	CbGeAlD
Almotriptan—HTR1B—Serotonin receptors—HTR1D—migraine	0.00174	0.0468	CbGpPWpGaD
Almotriptan—HTR1B—cranial nerve—migraine	0.00174	0.0309	CbGeAlD
Almotriptan—HTR1D—cranial nerve—migraine	0.00168	0.0299	CbGeAlD
Almotriptan—HTR1D—Serotonin receptors—HTR2B—migraine	0.00166	0.0445	CbGpPWpGaD
Almotriptan—HTR1B—Serotonin receptors—HTR2B—migraine	0.00162	0.0435	CbGpPWpGaD
Almotriptan—HTR1D—Serotonin receptors—HTR1B—migraine	0.00108	0.029	CbGpPWpGaD
Almotriptan—HTR1D—Serotonin receptors—HTR1A—migraine	0.00104	0.0279	CbGpPWpGaD
Almotriptan—HTR1B—Serotonin receptors—HTR1A—migraine	0.00102	0.0273	CbGpPWpGaD
Almotriptan—HTR1D—Serotonin receptors—HTR2C—migraine	0.001	0.0269	CbGpPWpGaD
Almotriptan—HTR1B—Serotonin receptors—HTR2C—migraine	0.000982	0.0264	CbGpPWpGaD
Almotriptan—MAOA—Serotonin Transporter Activity—SLC6A4—migraine	0.000944	0.0253	CbGpPWpGaD
Almotriptan—HTR1D—Serotonin receptors—HTR7—migraine	0.000878	0.0236	CbGpPWpGaD
Almotriptan—HTR1B—Serotonin receptors—HTR7—migraine	0.00086	0.0231	CbGpPWpGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR1D—migraine	0.000776	0.0209	CbGpPWpGaD
Almotriptan—HTR1D—Monoamine GPCRs—HTR2B—migraine	0.000737	0.0198	CbGpPWpGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR2B—migraine	0.000722	0.0194	CbGpPWpGaD
Almotriptan—HTR1B—blood vessel—migraine	0.000699	0.0124	CbGeAlD
Almotriptan—HTR1D—blood vessel—migraine	0.000676	0.012	CbGeAlD
Almotriptan—MAOA—nerve—migraine	0.000656	0.0117	CbGeAlD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR1D—migraine	0.000652	0.0175	CbGpPWpGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR2B—migraine	0.00062	0.0166	CbGpPWpGaD
Almotriptan—HTR1D—Serotonin receptors—HTR2A—migraine	0.000615	0.0165	CbGpPWpGaD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR2B—migraine	0.000607	0.0163	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000606	0.0163	CbGpPWpGaD
Almotriptan—Naratriptan—HTR1D—migraine	0.000606	0.113	CrCbGaD
Almotriptan—HTR1B—Serotonin receptors—HTR2A—migraine	0.000602	0.0162	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—HTR3A—migraine	0.000515	0.0138	CbGpPWpGaD
Almotriptan—Rizatriptan—HTR1D—migraine	0.000502	0.0935	CrCbGaD
Almotriptan—HTR1D—Monoamine GPCRs—HTR1B—migraine	0.00048	0.0129	CbGpPWpGaD
Almotriptan—HTR1D—Monoamine GPCRs—HTR1A—migraine	0.000462	0.0124	CbGpPWpGaD
Almotriptan—Zolmitriptan—HTR1D—migraine	0.000459	0.0856	CrCbGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR1A—migraine	0.000453	0.0122	CbGpPWpGaD
Almotriptan—HTR1D—Monoamine GPCRs—HTR2C—migraine	0.000447	0.012	CbGpPWpGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR2C—migraine	0.000437	0.0117	CbGpPWpGaD
Almotriptan—HTR1B—trigeminal ganglion—migraine	0.000432	0.00767	CbGeAlD
Almotriptan—HTR1D—trigeminal ganglion—migraine	0.000418	0.00743	CbGeAlD
Almotriptan—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—migraine	0.000416	0.0112	CbGpPWpGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR1B—migraine	0.000404	0.0108	CbGpPWpGaD
Almotriptan—HTR1D—Monoamine GPCRs—HTR7—migraine	0.000391	0.0105	CbGpPWpGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR1A—migraine	0.000389	0.0104	CbGpPWpGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR7—migraine	0.000383	0.0103	CbGpPWpGaD
Almotriptan—HTR1B—brainstem—migraine	0.000382	0.00679	CbGeAlD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR1A—migraine	0.000381	0.0102	CbGpPWpGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR2C—migraine	0.000375	0.0101	CbGpPWpGaD
Almotriptan—HTR1D—brainstem—migraine	0.00037	0.00657	CbGeAlD
Almotriptan—MAOA—neck—migraine	0.000368	0.00655	CbGeAlD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR2C—migraine	0.000368	0.00987	CbGpPWpGaD
Almotriptan—FMO3—head—migraine	0.00036	0.00639	CbGeAlD
Almotriptan—Naratriptan—HTR1B—migraine	0.00036	0.067	CrCbGaD
Almotriptan—FMO3—nervous system—migraine	0.000341	0.00606	CbGeAlD
Almotriptan—Sumatriptan—HTR3A—migraine	0.000339	0.0631	CrCbGaD
Almotriptan—Sumatriptan—HTR1D—migraine	0.000335	0.0624	CrCbGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR7—migraine	0.000329	0.00883	CbGpPWpGaD
Almotriptan—FMO3—central nervous system—migraine	0.000328	0.00584	CbGeAlD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR7—migraine	0.000322	0.00865	CbGpPWpGaD
Almotriptan—MAOA—trigeminal ganglion—migraine	0.000318	0.00565	CbGeAlD
Almotriptan—HTR1B—cardiovascular system—migraine	0.000312	0.00554	CbGeAlD
Almotriptan—HTR1D—cardiovascular system—migraine	0.000302	0.00536	CbGeAlD
Almotriptan—Rizatriptan—HTR1B—migraine	0.000298	0.0555	CrCbGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00029	0.00778	CbGpPWpGaD
Almotriptan—Naratriptan—HTR1A—migraine	0.000285	0.053	CrCbGaD
Almotriptan—MAOA—brainstem—migraine	0.000282	0.005	CbGeAlD
Almotriptan—HTR1D—Monoamine GPCRs—HTR2A—migraine	0.000274	0.00736	CbGpPWpGaD
Almotriptan—Zolmitriptan—HTR1B—migraine	0.000272	0.0508	CrCbGaD
Almotriptan—Eletriptan—HTR1D—migraine	0.000271	0.0505	CrCbGaD
Almotriptan—MAOA—Neuronal System—KCNK18—migraine	0.000269	0.00723	CbGpPWpGaD
Almotriptan—Eletriptan—HTR2B—migraine	0.000268	0.05	CrCbGaD
Almotriptan—HTR1B—Monoamine GPCRs—HTR2A—migraine	0.000268	0.0072	CbGpPWpGaD
Almotriptan—FMO3—brain—migraine	0.000261	0.00463	CbGeAlD
Almotriptan—MAOA—SIDS Susceptibility Pathways—HTR3A—migraine	0.000246	0.00662	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—HTR1A—migraine	0.000245	0.00658	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—TAC1—migraine	0.000241	0.00648	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000237	0.00636	CbGpPWpGaD
Almotriptan—Rizatriptan—HTR1A—migraine	0.000236	0.0439	CrCbGaD
Almotriptan—HTR1D—Amine ligand-binding receptors—HTR2A—migraine	0.00023	0.00619	CbGpPWpGaD
Almotriptan—MAOA—cardiovascular system—migraine	0.00023	0.00408	CbGeAlD
Almotriptan—HTR1B—Amine ligand-binding receptors—HTR2A—migraine	0.000225	0.00606	CbGpPWpGaD
Almotriptan—Zolmitriptan—HTR1A—migraine	0.000216	0.0402	CrCbGaD
Almotriptan—HTR1B—head—migraine	0.000211	0.00375	CbGeAlD
Almotriptan—MAOA—Oxidative Stress—FOS—migraine	0.000207	0.00557	CbGpPWpGaD
Almotriptan—HTR1D—head—migraine	0.000204	0.00363	CbGeAlD
Almotriptan—HTR1B—nervous system—migraine	0.0002	0.00356	CbGeAlD
Almotriptan—Sumatriptan—HTR1B—migraine	0.000199	0.037	CrCbGaD
Almotriptan—HTR1D—nervous system—migraine	0.000194	0.00344	CbGeAlD
Almotriptan—HTR1B—central nervous system—migraine	0.000193	0.00342	CbGeAlD
Almotriptan—HTR1D—central nervous system—migraine	0.000187	0.00332	CbGeAlD
Almotriptan—CYP2E1—cardiovascular system—migraine	0.000172	0.00307	CbGeAlD
Almotriptan—FMO3—SIDS Susceptibility Pathways—BDNF—migraine	0.000172	0.00461	CbGpPWpGaD
Almotriptan—MAOA—Transmission across Chemical Synapses—CACNA1A—migraine	0.000172	0.00461	CbGpPWpGaD
Almotriptan—CYP2D6—brainstem—migraine	0.000167	0.00297	CbGeAlD
Almotriptan—Eletriptan—HTR7—migraine	0.000166	0.0309	CrCbGaD
Almotriptan—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000166	0.00445	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—HTR1D—migraine	0.000161	0.00434	CbGpPWpGaD
Almotriptan—Eletriptan—HTR1B—migraine	0.000161	0.03	CrCbGaD
Almotriptan—Sumatriptan—HTR1A—migraine	0.000157	0.0293	CrCbGaD
Almotriptan—MAOA—head—migraine	0.000156	0.00277	CbGeAlD
Almotriptan—HTR1B—brain—migraine	0.000153	0.00272	CbGeAlD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00015	0.00402	CbGpPWpGaD
Almotriptan—HTR1D—brain—migraine	0.000148	0.00263	CbGeAlD
Almotriptan—MAOA—nervous system—migraine	0.000148	0.00262	CbGeAlD
Almotriptan—FMO3—SIDS Susceptibility Pathways—HTR2A—migraine	0.000145	0.0039	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000142	0.00382	CbGpPWpGaD
Almotriptan—MAOA—central nervous system—migraine	0.000142	0.00252	CbGeAlD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000139	0.00374	CbGpPWpGaD
Almotriptan—MAOA—cerebellum—migraine	0.000139	0.00247	CbGeAlD
Almotriptan—HTR1D—GPCR ligand binding—CALCRL—migraine	0.000137	0.00369	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—RAMP1—migraine	0.000137	0.00369	CbGpPWpGaD
Almotriptan—Abdominal discomfort—Topiramate—migraine	0.000137	0.00134	CcSEcCtD
Almotriptan—Eye disorder—Timolol—migraine	0.000136	0.00133	CcSEcCtD
Almotriptan—Rhinitis—Gabapentin—migraine	0.000136	0.00133	CcSEcCtD
Almotriptan—Tinnitus—Timolol—migraine	0.000136	0.00133	CcSEcCtD
Almotriptan—Cardiac disorder—Timolol—migraine	0.000136	0.00132	CcSEcCtD
Almotriptan—Feeling abnormal—Verapamil—migraine	0.000135	0.00132	CcSEcCtD
Almotriptan—Hypoaesthesia—Gabapentin—migraine	0.000135	0.00132	CcSEcCtD
Almotriptan—Pharyngitis—Gabapentin—migraine	0.000135	0.00132	CcSEcCtD
Almotriptan—Vision blurred—Valproic Acid—migraine	0.000135	0.00132	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—RAMP1—migraine	0.000135	0.00361	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CALCRL—migraine	0.000135	0.00361	CbGpPWpGaD
Almotriptan—Tremor—Valproic Acid—migraine	0.000134	0.00131	CcSEcCtD
Almotriptan—Ill-defined disorder—Valproic Acid—migraine	0.000133	0.0013	CcSEcCtD
Almotriptan—Immune system disorder—Timolol—migraine	0.000132	0.00129	CcSEcCtD
Almotriptan—Hypersensitivity—Propranolol—migraine	0.000132	0.00129	CcSEcCtD
Almotriptan—MAOA—Neuronal System—CACNA1A—migraine	0.000132	0.00353	CbGpPWpGaD
Almotriptan—Agitation—Valproic Acid—migraine	0.000131	0.00128	CcSEcCtD
Almotriptan—Visual impairment—Gabapentin—migraine	0.000131	0.00128	CcSEcCtD
Almotriptan—Angioedema—Valproic Acid—migraine	0.000131	0.00128	CcSEcCtD
Almotriptan—Photosensitivity reaction—Topiramate—migraine	0.00013	0.00128	CcSEcCtD
Almotriptan—Nausea—Amitriptyline—migraine	0.00013	0.00127	CcSEcCtD
Almotriptan—Hyperglycaemia—Topiramate—migraine	0.000129	0.00126	CcSEcCtD
Almotriptan—Malaise—Valproic Acid—migraine	0.000129	0.00126	CcSEcCtD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000128	0.00345	CbGpPWpGaD
Almotriptan—Vertigo—Valproic Acid—migraine	0.000128	0.00125	CcSEcCtD
Almotriptan—Asthenia—Propranolol—migraine	0.000128	0.00125	CcSEcCtD
Almotriptan—Mental disorder—Timolol—migraine	0.000128	0.00125	CcSEcCtD
Almotriptan—Eletriptan—HTR1A—migraine	0.000127	0.0237	CrCbGaD
Almotriptan—Erythema—Timolol—migraine	0.000127	0.00124	CcSEcCtD
Almotriptan—Eye disorder—Gabapentin—migraine	0.000127	0.00124	CcSEcCtD
Almotriptan—Tinnitus—Gabapentin—migraine	0.000127	0.00124	CcSEcCtD
Almotriptan—Cardiac disorder—Gabapentin—migraine	0.000126	0.00123	CcSEcCtD
Almotriptan—Palpitations—Valproic Acid—migraine	0.000126	0.00123	CcSEcCtD
Almotriptan—Neuropathy peripheral—Topiramate—migraine	0.000125	0.00122	CcSEcCtD
Almotriptan—Tension—Timolol—migraine	0.000125	0.00122	CcSEcCtD
Almotriptan—Dysgeusia—Timolol—migraine	0.000125	0.00122	CcSEcCtD
Almotriptan—Conjunctivitis—Topiramate—migraine	0.000124	0.00121	CcSEcCtD
Almotriptan—Nervousness—Timolol—migraine	0.000123	0.00121	CcSEcCtD
Almotriptan—Hypertension—Valproic Acid—migraine	0.000123	0.00121	CcSEcCtD
Almotriptan—Immune system disorder—Gabapentin—migraine	0.000123	0.0012	CcSEcCtD
Almotriptan—Diarrhoea—Propranolol—migraine	0.000122	0.0012	CcSEcCtD
Almotriptan—Chills—Gabapentin—migraine	0.000122	0.00119	CcSEcCtD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000122	0.00327	CbGpPWpGaD
Almotriptan—Chest pain—Valproic Acid—migraine	0.000122	0.00119	CcSEcCtD
Almotriptan—Myalgia—Valproic Acid—migraine	0.000122	0.00119	CcSEcCtD
Almotriptan—Arthralgia—Valproic Acid—migraine	0.000122	0.00119	CcSEcCtD
Almotriptan—Anxiety—Valproic Acid—migraine	0.000121	0.00118	CcSEcCtD
Almotriptan—Hypersensitivity—Verapamil—migraine	0.000121	0.00118	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000121	0.00118	CcSEcCtD
Almotriptan—Epistaxis—Topiramate—migraine	0.00012	0.00118	CcSEcCtD
Almotriptan—Discomfort—Valproic Acid—migraine	0.00012	0.00117	CcSEcCtD
Almotriptan—Vision blurred—Timolol—migraine	0.00012	0.00117	CcSEcCtD
Almotriptan—Sinusitis—Topiramate—migraine	0.00012	0.00117	CcSEcCtD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000119	0.00321	CbGpPWpGaD
Almotriptan—Mental disorder—Gabapentin—migraine	0.000119	0.00116	CcSEcCtD
Almotriptan—Dry mouth—Valproic Acid—migraine	0.000119	0.00116	CcSEcCtD
Almotriptan—Erythema—Gabapentin—migraine	0.000118	0.00116	CcSEcCtD
Almotriptan—Dizziness—Propranolol—migraine	0.000118	0.00115	CcSEcCtD
Almotriptan—Asthenia—Verapamil—migraine	0.000118	0.00115	CcSEcCtD
Almotriptan—Confusional state—Valproic Acid—migraine	0.000118	0.00115	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—HTR1A—migraine	0.000117	0.00315	CbGpPWpGaD
Almotriptan—CYP2E1—head—migraine	0.000117	0.00208	CbGeAlD
Almotriptan—Anaphylactic shock—Valproic Acid—migraine	0.000117	0.00114	CcSEcCtD
Almotriptan—Pruritus—Verapamil—migraine	0.000116	0.00114	CcSEcCtD
Almotriptan—Tension—Gabapentin—migraine	0.000116	0.00114	CcSEcCtD
Almotriptan—Angioedema—Timolol—migraine	0.000116	0.00114	CcSEcCtD
Almotriptan—Dysgeusia—Gabapentin—migraine	0.000116	0.00113	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TAC1—migraine	0.000115	0.0031	CbGpPWpGaD
Almotriptan—Nervousness—Gabapentin—migraine	0.000115	0.00112	CcSEcCtD
Almotriptan—Rhinitis—Topiramate—migraine	0.000115	0.00112	CcSEcCtD
Almotriptan—Back pain—Gabapentin—migraine	0.000115	0.00112	CcSEcCtD
Almotriptan—Nervous system disorder—Valproic Acid—migraine	0.000114	0.00112	CcSEcCtD
Almotriptan—Vertigo—Timolol—migraine	0.000114	0.00112	CcSEcCtD
Almotriptan—Syncope—Timolol—migraine	0.000114	0.00111	CcSEcCtD
Almotriptan—Hypoaesthesia—Topiramate—migraine	0.000114	0.00111	CcSEcCtD
Almotriptan—Tachycardia—Valproic Acid—migraine	0.000114	0.00111	CcSEcCtD
Almotriptan—Vomiting—Propranolol—migraine	0.000114	0.00111	CcSEcCtD
Almotriptan—Pharyngitis—Topiramate—migraine	0.000114	0.00111	CcSEcCtD
Almotriptan—Skin disorder—Valproic Acid—migraine	0.000113	0.00111	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000113	0.00304	CbGpPWpGaD
Almotriptan—MAOA—brain—migraine	0.000113	0.002	CbGeAlD
Almotriptan—Hyperhidrosis—Valproic Acid—migraine	0.000113	0.0011	CcSEcCtD
Almotriptan—Rash—Propranolol—migraine	0.000113	0.0011	CcSEcCtD
Almotriptan—Dermatitis—Propranolol—migraine	0.000113	0.0011	CcSEcCtD
Almotriptan—Diarrhoea—Verapamil—migraine	0.000112	0.0011	CcSEcCtD
Almotriptan—Palpitations—Timolol—migraine	0.000112	0.0011	CcSEcCtD
Almotriptan—Loss of consciousness—Timolol—migraine	0.000112	0.00109	CcSEcCtD
Almotriptan—Vision blurred—Gabapentin—migraine	0.000112	0.00109	CcSEcCtD
Almotriptan—Melatonin—ESR1—migraine	0.000111	0.0207	CrCbGaD
Almotriptan—Tremor—Gabapentin—migraine	0.000111	0.00108	CcSEcCtD
Almotriptan—CYP2E1—nervous system—migraine	0.000111	0.00197	CbGeAlD
Almotriptan—Visual impairment—Topiramate—migraine	0.00011	0.00108	CcSEcCtD
Almotriptan—Ill-defined disorder—Gabapentin—migraine	0.00011	0.00107	CcSEcCtD
Almotriptan—Hypertension—Timolol—migraine	0.00011	0.00107	CcSEcCtD
Almotriptan—Agitation—Gabapentin—migraine	0.000109	0.00106	CcSEcCtD
Almotriptan—Dizziness—Verapamil—migraine	0.000109	0.00106	CcSEcCtD
Almotriptan—Myalgia—Timolol—migraine	0.000108	0.00106	CcSEcCtD
Almotriptan—Arthralgia—Timolol—migraine	0.000108	0.00106	CcSEcCtD
Almotriptan—Chest pain—Timolol—migraine	0.000108	0.00106	CcSEcCtD
Almotriptan—Angioedema—Gabapentin—migraine	0.000108	0.00106	CcSEcCtD
Almotriptan—Anxiety—Timolol—migraine	0.000108	0.00105	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000108	0.00105	CcSEcCtD
Almotriptan—Discomfort—Timolol—migraine	0.000107	0.00105	CcSEcCtD
Almotriptan—Eye disorder—Topiramate—migraine	0.000107	0.00105	CcSEcCtD
Almotriptan—Malaise—Gabapentin—migraine	0.000107	0.00104	CcSEcCtD
Almotriptan—Tinnitus—Topiramate—migraine	0.000107	0.00104	CcSEcCtD
Almotriptan—CYP2E1—central nervous system—migraine	0.000107	0.00189	CbGeAlD
Almotriptan—Vertigo—Gabapentin—migraine	0.000106	0.00104	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Valproic Acid—migraine	0.000106	0.00104	CcSEcCtD
Almotriptan—Cardiac disorder—Topiramate—migraine	0.000106	0.00104	CcSEcCtD
Almotriptan—Syncope—Gabapentin—migraine	0.000106	0.00104	CcSEcCtD
Almotriptan—Nausea—Propranolol—migraine	0.000106	0.00104	CcSEcCtD
Almotriptan—Dry mouth—Timolol—migraine	0.000106	0.00103	CcSEcCtD
Almotriptan—Insomnia—Valproic Acid—migraine	0.000105	0.00103	CcSEcCtD
Almotriptan—Paraesthesia—Valproic Acid—migraine	0.000105	0.00102	CcSEcCtD
Almotriptan—Palpitations—Gabapentin—migraine	0.000105	0.00102	CcSEcCtD
Almotriptan—Confusional state—Timolol—migraine	0.000105	0.00102	CcSEcCtD
Almotriptan—Vomiting—Verapamil—migraine	0.000105	0.00102	CcSEcCtD
Almotriptan—CYP2E1—cerebellum—migraine	0.000104	0.00185	CbGeAlD
Almotriptan—Loss of consciousness—Gabapentin—migraine	0.000104	0.00102	CcSEcCtD
Almotriptan—Dyspnoea—Valproic Acid—migraine	0.000104	0.00102	CcSEcCtD
Almotriptan—Anaphylactic shock—Timolol—migraine	0.000104	0.00101	CcSEcCtD
Almotriptan—Rash—Verapamil—migraine	0.000104	0.00101	CcSEcCtD
Almotriptan—Somnolence—Valproic Acid—migraine	0.000104	0.00101	CcSEcCtD
Almotriptan—Dermatitis—Verapamil—migraine	0.000104	0.00101	CcSEcCtD
Almotriptan—Immune system disorder—Topiramate—migraine	0.000103	0.00101	CcSEcCtD
Almotriptan—Headache—Verapamil—migraine	0.000103	0.00101	CcSEcCtD
Almotriptan—Chills—Topiramate—migraine	0.000103	0.001	CcSEcCtD
Almotriptan—Dyspepsia—Valproic Acid—migraine	0.000103	0.001	CcSEcCtD
Almotriptan—Convulsion—Gabapentin—migraine	0.000103	0.001	CcSEcCtD
Almotriptan—Hypertension—Gabapentin—migraine	0.000102	0.000999	CcSEcCtD
Almotriptan—Shock—Timolol—migraine	0.000102	0.000998	CcSEcCtD
Almotriptan—Nervous system disorder—Timolol—migraine	0.000102	0.000995	CcSEcCtD
Almotriptan—Chest pain—Gabapentin—migraine	0.000101	0.000985	CcSEcCtD
Almotriptan—Myalgia—Gabapentin—migraine	0.000101	0.000985	CcSEcCtD
Almotriptan—Arthralgia—Gabapentin—migraine	0.000101	0.000985	CcSEcCtD
Almotriptan—Skin disorder—Timolol—migraine	0.000101	0.000985	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Valproic Acid—migraine	0.000101	0.000983	CcSEcCtD
Almotriptan—CYP2C8—brain—migraine	0.000101	0.00179	CbGeAlD
Almotriptan—Fatigue—Valproic Acid—migraine	0.0001	0.000982	CcSEcCtD
Almotriptan—Anxiety—Gabapentin—migraine	0.0001	0.000982	CcSEcCtD
Almotriptan—Hyperhidrosis—Timolol—migraine	0.0001	0.00098	CcSEcCtD
Almotriptan—Mental disorder—Topiramate—migraine	0.0001	0.00098	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.0001	0.000978	CcSEcCtD
Almotriptan—HTR1D—G alpha (i) signalling events—HTR1B—migraine	9.99e-05	0.00268	CbGpPWpGaD
Almotriptan—Pain—Valproic Acid—migraine	9.97e-05	0.000974	CcSEcCtD
Almotriptan—Erythema—Topiramate—migraine	9.96e-05	0.000974	CcSEcCtD
Almotriptan—Discomfort—Gabapentin—migraine	9.96e-05	0.000973	CcSEcCtD
Almotriptan—Dry mouth—Gabapentin—migraine	9.86e-05	0.000963	CcSEcCtD
Almotriptan—Tension—Topiramate—migraine	9.78e-05	0.000955	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—HTR1D—migraine	9.77e-05	0.00263	CbGpPWpGaD
Almotriptan—Nausea—Verapamil—migraine	9.77e-05	0.000954	CcSEcCtD
Almotriptan—Dysgeusia—Topiramate—migraine	9.76e-05	0.000953	CcSEcCtD
Almotriptan—Confusional state—Gabapentin—migraine	9.74e-05	0.000952	CcSEcCtD
Almotriptan—Nervousness—Topiramate—migraine	9.68e-05	0.000946	CcSEcCtD
Almotriptan—Anaphylactic shock—Gabapentin—migraine	9.66e-05	0.000944	CcSEcCtD
Almotriptan—Back pain—Topiramate—migraine	9.64e-05	0.000942	CcSEcCtD
Almotriptan—HTR1D—G alpha (i) signalling events—HTR1A—migraine	9.61e-05	0.00258	CbGpPWpGaD
Almotriptan—Feeling abnormal—Valproic Acid—migraine	9.61e-05	0.000939	CcSEcCtD
Almotriptan—Gastrointestinal pain—Valproic Acid—migraine	9.53e-05	0.000932	CcSEcCtD
Almotriptan—Shock—Gabapentin—migraine	9.51e-05	0.000929	CcSEcCtD
Almotriptan—Nervous system disorder—Gabapentin—migraine	9.48e-05	0.000926	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Timolol—migraine	9.45e-05	0.000924	CcSEcCtD
Almotriptan—Tachycardia—Gabapentin—migraine	9.43e-05	0.000922	CcSEcCtD
Almotriptan—HTR1B—G alpha (i) signalling events—HTR1A—migraine	9.41e-05	0.00253	CbGpPWpGaD
Almotriptan—Vision blurred—Topiramate—migraine	9.39e-05	0.000917	CcSEcCtD
Almotriptan—Skin disorder—Gabapentin—migraine	9.39e-05	0.000917	CcSEcCtD
Almotriptan—Insomnia—Timolol—migraine	9.39e-05	0.000917	CcSEcCtD
Almotriptan—Hyperhidrosis—Gabapentin—migraine	9.34e-05	0.000913	CcSEcCtD
Almotriptan—Tremor—Topiramate—migraine	9.33e-05	0.000912	CcSEcCtD
Almotriptan—Paraesthesia—Timolol—migraine	9.32e-05	0.000911	CcSEcCtD
Almotriptan—HTR1D—GPCR ligand binding—HTR2B—migraine	9.28e-05	0.00249	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.27e-05	0.00249	CbGpPWpGaD
Almotriptan—Dyspnoea—Timolol—migraine	9.25e-05	0.000904	CcSEcCtD
Almotriptan—CYP2D6—head—migraine	9.25e-05	0.00164	CbGeAlD
Almotriptan—Ill-defined disorder—Topiramate—migraine	9.24e-05	0.000903	CcSEcCtD
Almotriptan—Somnolence—Timolol—migraine	9.23e-05	0.000902	CcSEcCtD
Almotriptan—Body temperature increased—Valproic Acid—migraine	9.21e-05	0.000901	CcSEcCtD
Almotriptan—Abdominal pain—Valproic Acid—migraine	9.21e-05	0.000901	CcSEcCtD
Almotriptan—Agitation—Topiramate—migraine	9.15e-05	0.000895	CcSEcCtD
Almotriptan—Dyspepsia—Timolol—migraine	9.13e-05	0.000893	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—HTR2B—migraine	9.09e-05	0.00244	CbGpPWpGaD
Almotriptan—Malaise—Topiramate—migraine	8.98e-05	0.000878	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Timolol—migraine	8.96e-05	0.000876	CcSEcCtD
Almotriptan—Vertigo—Topiramate—migraine	8.95e-05	0.000875	CcSEcCtD
Almotriptan—Fatigue—Timolol—migraine	8.95e-05	0.000874	CcSEcCtD
Almotriptan—Syncope—Topiramate—migraine	8.93e-05	0.000873	CcSEcCtD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.92e-05	0.0024	CbGpPWpGaD
Almotriptan—CYP3A4—nervous system—migraine	8.91e-05	0.00158	CbGeAlD
Almotriptan—Pain—Timolol—migraine	8.87e-05	0.000867	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Gabapentin—migraine	8.8e-05	0.00086	CcSEcCtD
Almotriptan—Palpitations—Topiramate—migraine	8.8e-05	0.00086	CcSEcCtD
Almotriptan—CYP2D6—nervous system—migraine	8.77e-05	0.00156	CbGeAlD
Almotriptan—Loss of consciousness—Topiramate—migraine	8.76e-05	0.000856	CcSEcCtD
Almotriptan—Insomnia—Gabapentin—migraine	8.74e-05	0.000854	CcSEcCtD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.74e-05	0.00235	CbGpPWpGaD
Almotriptan—Paraesthesia—Gabapentin—migraine	8.68e-05	0.000848	CcSEcCtD
Almotriptan—Convulsion—Topiramate—migraine	8.63e-05	0.000843	CcSEcCtD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.62e-05	0.00231	CbGpPWpGaD
Almotriptan—Dyspnoea—Gabapentin—migraine	8.62e-05	0.000842	CcSEcCtD
Almotriptan—Hypertension—Topiramate—migraine	8.6e-05	0.00084	CcSEcCtD
Almotriptan—Somnolence—Gabapentin—migraine	8.59e-05	0.00084	CcSEcCtD
Almotriptan—Hypersensitivity—Valproic Acid—migraine	8.59e-05	0.000839	CcSEcCtD
Almotriptan—CYP3A4—central nervous system—migraine	8.58e-05	0.00152	CbGeAlD
Almotriptan—Feeling abnormal—Timolol—migraine	8.55e-05	0.000836	CcSEcCtD
Almotriptan—Dyspepsia—Gabapentin—migraine	8.51e-05	0.000831	CcSEcCtD
Almotriptan—Gastrointestinal pain—Timolol—migraine	8.49e-05	0.000829	CcSEcCtD
Almotriptan—Myalgia—Topiramate—migraine	8.48e-05	0.000829	CcSEcCtD
Almotriptan—Arthralgia—Topiramate—migraine	8.48e-05	0.000829	CcSEcCtD
Almotriptan—Chest pain—Topiramate—migraine	8.48e-05	0.000829	CcSEcCtD
Almotriptan—CYP2E1—brain—migraine	8.46e-05	0.0015	CbGeAlD
Almotriptan—Anxiety—Topiramate—migraine	8.45e-05	0.000826	CcSEcCtD
Almotriptan—CYP2D6—central nervous system—migraine	8.44e-05	0.0015	CbGeAlD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.44e-05	0.00227	CbGpPWpGaD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	8.42e-05	0.000823	CcSEcCtD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.38e-05	0.00225	CbGpPWpGaD
Almotriptan—Discomfort—Topiramate—migraine	8.38e-05	0.000819	CcSEcCtD
Almotriptan—Asthenia—Valproic Acid—migraine	8.36e-05	0.000817	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Gabapentin—migraine	8.34e-05	0.000815	CcSEcCtD
Almotriptan—Fatigue—Gabapentin—migraine	8.33e-05	0.000814	CcSEcCtD
Almotriptan—Dry mouth—Topiramate—migraine	8.29e-05	0.000811	CcSEcCtD
Almotriptan—Pain—Gabapentin—migraine	8.26e-05	0.000808	CcSEcCtD
Almotriptan—CYP2D6—cerebellum—migraine	8.25e-05	0.00147	CbGeAlD
Almotriptan—Pruritus—Valproic Acid—migraine	8.25e-05	0.000806	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—BDNF—migraine	8.21e-05	0.00221	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.21e-05	0.0022	CbGpPWpGaD
Almotriptan—Abdominal pain—Timolol—migraine	8.2e-05	0.000802	CcSEcCtD
Almotriptan—Body temperature increased—Timolol—migraine	8.2e-05	0.000802	CcSEcCtD
Almotriptan—Confusional state—Topiramate—migraine	8.2e-05	0.000801	CcSEcCtD
Almotriptan—Shock—Topiramate—migraine	8e-05	0.000782	CcSEcCtD
Almotriptan—Diarrhoea—Valproic Acid—migraine	7.98e-05	0.000779	CcSEcCtD
Almotriptan—Nervous system disorder—Topiramate—migraine	7.97e-05	0.000779	CcSEcCtD
Almotriptan—Feeling abnormal—Gabapentin—migraine	7.96e-05	0.000778	CcSEcCtD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.94e-05	0.00213	CbGpPWpGaD
Almotriptan—Tachycardia—Topiramate—migraine	7.93e-05	0.000775	CcSEcCtD
Almotriptan—Gastrointestinal pain—Gabapentin—migraine	7.9e-05	0.000772	CcSEcCtD
Almotriptan—Skin disorder—Topiramate—migraine	7.9e-05	0.000772	CcSEcCtD
Almotriptan—Hyperhidrosis—Topiramate—migraine	7.86e-05	0.000768	CcSEcCtD
Almotriptan—HTR1D—GPCR downstream signaling—CALCRL—migraine	7.76e-05	0.00209	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—RAMP1—migraine	7.76e-05	0.00209	CbGpPWpGaD
Almotriptan—Dizziness—Valproic Acid—migraine	7.71e-05	0.000753	CcSEcCtD
Almotriptan—Hypersensitivity—Timolol—migraine	7.65e-05	0.000747	CcSEcCtD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.64e-05	0.00205	CbGpPWpGaD
Almotriptan—Abdominal pain—Gabapentin—migraine	7.64e-05	0.000747	CcSEcCtD
Almotriptan—Body temperature increased—Gabapentin—migraine	7.64e-05	0.000747	CcSEcCtD
Almotriptan—HTR1B—GPCR downstream signaling—RAMP1—migraine	7.6e-05	0.00204	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CALCRL—migraine	7.6e-05	0.00204	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.55e-05	0.00203	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.53e-05	0.00202	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.53e-05	0.00202	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.48e-05	0.00201	CbGpPWpGaD
Almotriptan—Asthenia—Timolol—migraine	7.45e-05	0.000728	CcSEcCtD
Almotriptan—Vomiting—Valproic Acid—migraine	7.41e-05	0.000724	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Topiramate—migraine	7.41e-05	0.000724	CcSEcCtD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.39e-05	0.00199	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.38e-05	0.00198	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.37e-05	0.00198	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.37e-05	0.00198	CbGpPWpGaD
Almotriptan—Insomnia—Topiramate—migraine	7.35e-05	0.000719	CcSEcCtD
Almotriptan—Rash—Valproic Acid—migraine	7.35e-05	0.000718	CcSEcCtD
Almotriptan—Dermatitis—Valproic Acid—migraine	7.34e-05	0.000718	CcSEcCtD
Almotriptan—Pruritus—Timolol—migraine	7.34e-05	0.000717	CcSEcCtD
Almotriptan—Headache—Valproic Acid—migraine	7.3e-05	0.000714	CcSEcCtD
Almotriptan—Paraesthesia—Topiramate—migraine	7.3e-05	0.000713	CcSEcCtD
Almotriptan—Dyspnoea—Topiramate—migraine	7.25e-05	0.000708	CcSEcCtD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.23e-05	0.00194	CbGpPWpGaD
Almotriptan—Somnolence—Topiramate—migraine	7.23e-05	0.000706	CcSEcCtD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.18e-05	0.00193	CbGpPWpGaD
Almotriptan—Dyspepsia—Topiramate—migraine	7.16e-05	0.000699	CcSEcCtD
Almotriptan—Hypersensitivity—Gabapentin—migraine	7.12e-05	0.000696	CcSEcCtD
Almotriptan—Diarrhoea—Timolol—migraine	7.1e-05	0.000694	CcSEcCtD
Almotriptan—HTR1D—Signaling by GPCR—CALCRL—migraine	7.05e-05	0.00189	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—RAMP1—migraine	7.05e-05	0.00189	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.03e-05	0.00189	CbGpPWpGaD
Almotriptan—Gastrointestinal disorder—Topiramate—migraine	7.02e-05	0.000686	CcSEcCtD
Almotriptan—Fatigue—Topiramate—migraine	7.01e-05	0.000685	CcSEcCtD
Almotriptan—Pain—Topiramate—migraine	6.95e-05	0.000679	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—migraine	6.94e-05	0.00186	CbGpPWpGaD
Almotriptan—Asthenia—Gabapentin—migraine	6.93e-05	0.000678	CcSEcCtD
Almotriptan—FMO3—Metabolism—CACNA1A—migraine	6.93e-05	0.00186	CbGpPWpGaD
Almotriptan—Nausea—Valproic Acid—migraine	6.92e-05	0.000677	CcSEcCtD
Almotriptan—HTR1B—Signaling by GPCR—CALCRL—migraine	6.9e-05	0.00185	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—RAMP1—migraine	6.9e-05	0.00185	CbGpPWpGaD
Almotriptan—Dizziness—Timolol—migraine	6.86e-05	0.000671	CcSEcCtD
Almotriptan—Pruritus—Gabapentin—migraine	6.84e-05	0.000668	CcSEcCtD
Almotriptan—CYP2D6—brain—migraine	6.7e-05	0.00119	CbGeAlD
Almotriptan—Feeling abnormal—Topiramate—migraine	6.7e-05	0.000655	CcSEcCtD
Almotriptan—Gastrointestinal pain—Topiramate—migraine	6.65e-05	0.00065	CcSEcCtD
Almotriptan—Diarrhoea—Gabapentin—migraine	6.61e-05	0.000646	CcSEcCtD
Almotriptan—Vomiting—Timolol—migraine	6.6e-05	0.000645	CcSEcCtD
Almotriptan—Rash—Timolol—migraine	6.54e-05	0.000639	CcSEcCtD
Almotriptan—Dermatitis—Timolol—migraine	6.54e-05	0.000639	CcSEcCtD
Almotriptan—Headache—Timolol—migraine	6.5e-05	0.000635	CcSEcCtD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.47e-05	0.00174	CbGpPWpGaD
Almotriptan—Body temperature increased—Topiramate—migraine	6.43e-05	0.000628	CcSEcCtD
Almotriptan—Abdominal pain—Topiramate—migraine	6.43e-05	0.000628	CcSEcCtD
Almotriptan—Dizziness—Gabapentin—migraine	6.39e-05	0.000624	CcSEcCtD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.33e-05	0.0017	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—TNF—migraine	6.24e-05	0.00168	CbGpPWpGaD
Almotriptan—Nausea—Timolol—migraine	6.16e-05	0.000602	CcSEcCtD
Almotriptan—Vomiting—Gabapentin—migraine	6.14e-05	0.0006	CcSEcCtD
Almotriptan—Rash—Gabapentin—migraine	6.09e-05	0.000595	CcSEcCtD
Almotriptan—Dermatitis—Gabapentin—migraine	6.09e-05	0.000595	CcSEcCtD
Almotriptan—Headache—Gabapentin—migraine	6.05e-05	0.000592	CcSEcCtD
Almotriptan—HTR1D—GPCR ligand binding—HTR1B—migraine	6.05e-05	0.00162	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	6.03e-05	0.00162	CbGpPWpGaD
Almotriptan—Hypersensitivity—Topiramate—migraine	5.99e-05	0.000585	CcSEcCtD
Almotriptan—Asthenia—Topiramate—migraine	5.83e-05	0.00057	CcSEcCtD
Almotriptan—HTR1D—GPCR ligand binding—HTR1A—migraine	5.82e-05	0.00156	CbGpPWpGaD
Almotriptan—Pruritus—Topiramate—migraine	5.75e-05	0.000562	CcSEcCtD
Almotriptan—Nausea—Gabapentin—migraine	5.74e-05	0.000561	CcSEcCtD
Almotriptan—HTR1D—GPCR ligand binding—NPS—migraine	5.73e-05	0.00154	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—TAC1—migraine	5.73e-05	0.00154	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HTR1A—migraine	5.7e-05	0.00153	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HTR2C—migraine	5.62e-05	0.00151	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—NPS—migraine	5.61e-05	0.00151	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—TAC1—migraine	5.61e-05	0.00151	CbGpPWpGaD
Almotriptan—Diarrhoea—Topiramate—migraine	5.56e-05	0.000544	CcSEcCtD
Almotriptan—HTR1B—GPCR downstream signaling—HTR1D—migraine	5.52e-05	0.00148	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HTR2C—migraine	5.5e-05	0.00148	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—EDNRA—migraine	5.47e-05	0.00147	CbGpPWpGaD
Almotriptan—Dizziness—Topiramate—migraine	5.38e-05	0.000525	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—EDNRA—migraine	5.35e-05	0.00144	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.29e-05	0.00142	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CALCA—migraine	5.26e-05	0.00141	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR2B—migraine	5.24e-05	0.00141	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.18e-05	0.00139	CbGpPWpGaD
Almotriptan—Vomiting—Topiramate—migraine	5.17e-05	0.000505	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—CALCA—migraine	5.15e-05	0.00138	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR2B—migraine	5.13e-05	0.00138	CbGpPWpGaD
Almotriptan—Rash—Topiramate—migraine	5.13e-05	0.000501	CcSEcCtD
Almotriptan—Dermatitis—Topiramate—migraine	5.12e-05	0.0005	CcSEcCtD
Almotriptan—Headache—Topiramate—migraine	5.09e-05	0.000498	CcSEcCtD
Almotriptan—HTR1B—Signaling by GPCR—HTR1D—migraine	5.02e-05	0.00135	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HTR7—migraine	4.92e-05	0.00132	CbGpPWpGaD
Almotriptan—Nausea—Topiramate—migraine	4.83e-05	0.000472	CcSEcCtD
Almotriptan—HTR1B—GPCR ligand binding—HTR7—migraine	4.82e-05	0.0013	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR2B—migraine	4.76e-05	0.00128	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR2B—migraine	4.66e-05	0.00125	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.53e-05	0.00122	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.43e-05	0.00119	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CALCRL—migraine	4.16e-05	0.00112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RAMP1—migraine	4.16e-05	0.00112	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CALCRL—migraine	4.08e-05	0.0011	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RAMP1—migraine	4.08e-05	0.0011	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HTR2A—migraine	3.45e-05	0.000926	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR1B—migraine	3.42e-05	0.000918	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HTR2A—migraine	3.38e-05	0.000907	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CACNA1A—migraine	3.31e-05	0.00089	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR1A—migraine	3.29e-05	0.000884	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—TAC1—migraine	3.24e-05	0.00087	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—NPS—migraine	3.24e-05	0.00087	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR1A—migraine	3.22e-05	0.000865	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR2C—migraine	3.18e-05	0.000853	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—TAC1—migraine	3.17e-05	0.000852	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—NPS—migraine	3.17e-05	0.000852	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR2C—migraine	3.11e-05	0.000836	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR1B—migraine	3.1e-05	0.000834	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—EDNRA—migraine	3.09e-05	0.00083	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—EDNRA—migraine	3.03e-05	0.000813	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR1A—migraine	2.99e-05	0.000802	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—migraine	2.98e-05	0.000801	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CALCA—migraine	2.97e-05	0.000799	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR1D—migraine	2.96e-05	0.000796	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—NPS—migraine	2.94e-05	0.00079	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—TAC1—migraine	2.94e-05	0.00079	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR1A—migraine	2.93e-05	0.000786	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	2.92e-05	0.000785	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	2.92e-05	0.000785	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CALCA—migraine	2.91e-05	0.000783	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR2C—migraine	2.89e-05	0.000775	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—NPS—migraine	2.88e-05	0.000774	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—TAC1—migraine	2.88e-05	0.000774	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR2C—migraine	2.82e-05	0.000759	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2B—migraine	2.81e-05	0.000756	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EDNRA—migraine	2.81e-05	0.000754	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR7—migraine	2.78e-05	0.000748	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2B—migraine	2.75e-05	0.00074	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EDNRA—migraine	2.75e-05	0.000738	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR7—migraine	2.72e-05	0.000732	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CALCA—migraine	2.7e-05	0.000726	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CALCA—migraine	2.65e-05	0.000711	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR7—migraine	2.53e-05	0.000679	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LRP1—migraine	2.48e-05	0.000665	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR7—migraine	2.47e-05	0.000665	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LRP1—migraine	2.42e-05	0.000651	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—MTHFR—migraine	2.29e-05	0.000616	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CACNA1A—migraine	2.03e-05	0.000546	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR2A—migraine	1.95e-05	0.000524	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR2A—migraine	1.91e-05	0.000513	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH4—migraine	1.9e-05	0.00051	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH4—migraine	1.86e-05	0.0005	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR1B—migraine	1.83e-05	0.000492	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR2A—migraine	1.77e-05	0.000475	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR1A—migraine	1.76e-05	0.000474	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CACNA1A—migraine	1.76e-05	0.000472	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PGR—migraine	1.74e-05	0.000467	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NPS—migraine	1.74e-05	0.000467	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TAC1—migraine	1.74e-05	0.000467	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR2A—migraine	1.73e-05	0.000466	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR1A—migraine	1.73e-05	0.000464	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2C—migraine	1.7e-05	0.000458	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TAC1—migraine	1.7e-05	0.000457	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NPS—migraine	1.7e-05	0.000457	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PGR—migraine	1.7e-05	0.000457	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2C—migraine	1.67e-05	0.000448	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EDNRA—migraine	1.66e-05	0.000445	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EDNRA—migraine	1.62e-05	0.000436	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH3—migraine	1.62e-05	0.000434	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CALCA—migraine	1.6e-05	0.000429	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH3—migraine	1.58e-05	0.000425	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CACNA1A—migraine	1.57e-05	0.000421	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CALCA—migraine	1.56e-05	0.00042	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR7—migraine	1.49e-05	0.000401	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR7—migraine	1.46e-05	0.000393	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CACNA1A—migraine	1.44e-05	0.000387	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFBR2—migraine	1.29e-05	0.000345	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFBR2—migraine	1.26e-05	0.000338	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CACNA1A—migraine	1.22e-05	0.000328	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—migraine	1.1e-05	0.000294	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2A—migraine	1.05e-05	0.000281	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2A—migraine	1.02e-05	0.000275	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CACNA1A—migraine	9.43e-06	0.000253	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—migraine	9.28e-06	0.000249	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—migraine	9.09e-06	0.000244	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—migraine	6.72e-06	0.000181	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—migraine	5.81e-06	0.000156	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—migraine	5.19e-06	0.000139	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—migraine	4.77e-06	0.000128	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—migraine	4.04e-06	0.000109	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—migraine	3.12e-06	8.38e-05	CbGpPWpGaD
